Today: 19 April 2026
Booking Holdings (BKNG) stock slips as Booking.com expands Navan tie-up ahead of Feb. 18 results

Booking Holdings (BKNG) stock slips as Booking.com expands Navan tie-up ahead of Feb. 18 results

New York, January 22, 2026, 21:14 EST — Market closed

Booking Holdings Inc. shares edged down 0.25% to close at $5,150.90 on Thursday, capping a volatile three-day stretch for the online travel giant’s stock. The price fluctuated between $5,119.07 and $5,248.61, with roughly 220,000 shares traded.

This shift takes on extra weight with Booking’s fourth-quarter and full-year update less than a month away. Investors are sharp on any signals tied to demand, particularly business travel. Even a cautious note on bookings or margins can nudge the stock, despite the report’s operational focus.

Timing is another factor. U.S. markets reopen Friday, bringing new data on activity and confidence that could directly impact travel stocks, which often move with shifts in consumer sentiment and corporate spending.

Wall Street closed Thursday on a positive note: the Dow rose 0.63%, the S&P 500 gained 0.55%, and the Nasdaq climbed 0.91%. Against this backdrop, Booking’s slight decline seemed more an isolated blip than a sign of wider market caution.

Within the travel sector, Expedia climbed roughly 3% during the session. Tripadvisor and MakeMyTrip also saw gains, according to market data. Booking, however, slipped slightly.

On Thursday, corporate travel and expense platform Navan announced it has boosted its direct connection with Booking.com, aiming to offer more lodging options and discounts within Navan’s business travel tools. The two companies called the upgrade an enhanced “API” integration — software that enables data sharing between systems — designed to unlock more properties and rates in managed travel programs. “It’s about adding more value to every business trip,” said Navan’s Dane Molter. Booking.com’s Thibaut Leroux added the partnership broadens “business travelers’ choices.” Navan

Booking announced its calendar for the week, scheduling the release of its fourth-quarter and full-year 2025 financial results around 4:00 p.m. ET on Feb. 18. A conference call will follow at 4:30 p.m. ET. The company, a global player in online travel and related services, operates brands like Booking.com, Priceline, Agoda, KAYAK, and OpenTable.

Investors will zero in on a few clear but tough metrics in that report: growth in bookings and room nights, evidence of pricing power, and whether marketing expenses are climbing faster than revenue. If demand dips or competition drives deeper discounts, the stock usually reacts fast.

Friday’s U.S. calendar includes S&P Global’s flash manufacturing and services PMI numbers, along with the University of Michigan’s final consumer sentiment reading for January. These reports could shift rate expectations and the dollar’s direction, key factors for travel spending and multinational companies reporting in different currencies.

Still, the situation is double-edged. The Navan integration might not have an immediate impact, and corporate travel budgets can shrink quickly if executives grow wary. Plus, a stronger dollar could dampen reported growth for firms with significant overseas operations, even if actual demand stays solid.

Booking Holdings is set to report earnings on Feb. 18, after the U.S. market closes, followed by a Q&A session.

Stock Market Today

  • 2 TSX Stocks Under $100 with Strong Upside Potential
    April 18, 2026, 9:56 PM EDT. CES Energy (TSX:CEU) and Bird Construction are two TSX-listed stocks priced below $100 that offer significant growth potential. CES Energy provides consumable chemical solutions to oil and gas producers, benefiting from rising service intensity and demand for advanced chemical treatments. Despite softer drilling activity, CES's revenue growth remains robust, supported by its asset-light model and strategic acquisitions. Macro trends like growing global energy demand and LNG infrastructure expansion further boost its outlook. Bird Construction, also trading under $100, stands out for its presence in the construction sector, which benefits from infrastructure spending and urban development. Both companies show disciplined capital allocation and resilient revenue drivers, making them attractive for investors seeking accessible entry points and potential capital appreciation on the TSX.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week
Previous Story

AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week

Paytm share price whipsaws after Investec starts coverage with ‘Buy’ and ₹1,550 target
Next Story

Paytm share price whipsaws after Investec starts coverage with ‘Buy’ and ₹1,550 target

Go toTop